<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38776311</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>22</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Acute and long-term outcomes of SARS-CoV-2 infection in school-aged children in England: Study protocol for the joint analysis of the COVID-19 schools infection survey (SIS) and the COVID-19 mapping and mitigation in schools (CoMMinS) study.</ArticleTitle><Pagination><StartPage>e0303892</StartPage><MedlinePgn>e0303892</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0303892</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0303892</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The symptom profiles of acute SARS-CoV-2 infection and long-COVID in children and young people (CYP), risk factors, and associated healthcare needs, are poorly defined. The Schools Infection Survey 1 (SIS-1) was a nationwide study of SARS-CoV-2 infection in primary and secondary schools in England during the 2020/21 school year. The Covid-19 Mapping and Mitigation in Schools (CoMMinS) study was conducted in schools in the Bristol area over a similar period. Both studies conducted testing to identify current and previous SARS-CoV-2 infection, and recorded symptoms and school attendance. These research data have been linked to routine electronic health record (EHR) data.</AbstractText><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">To better understand the short- and long-term consequences of SARS-CoV-2 infection, and their risk factors, in CYP.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Retrospective cohort and nested case-control analyses will be conducted for SIS-1 and CoMMinS data linked to EHR data for the association between (1) acute symptomatic SARS-CoV-2 infection and risk factors; (2) SARS-CoV-2 infection and long-term effects on health: (a) persistent symptoms; (b) any new diagnosis; (c) a new prescription in primary care; (d) health service attendance; (e) a high rate of school absence.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Our study will improve understanding of long-COVID in CYP by characterising the trajectory of long-COVID in CYP in terms of things like symptoms and diagnoses of conditions. The research will inform which groups of CYP are more likely to get acute- and long-term outcomes of SARS-CoV-2 infection, and patterns of related healthcare-seeking behaviour, relevant for healthcare service planning. Digested information will be produced for affected families, doctors, schools, and the public, as appropriate.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Linked SIS-1 and CoMMinS data represent a unique and rich resource for understanding the impact of SARS-CoV-2 infection on children's health, benefiting from enhanced SARS-CoV-2 testing and ability to assess a wide range of outcomes.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Looker et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Looker</LastName><ForeName>Katharine J</ForeName><Initials>KJ</Initials><Identifier Source="ORCID">0000-0002-3375-0807</Identifier><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McClenaghan</LastName><ForeName>Elliot</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Judd</LastName><ForeName>Alison</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, South Wales, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pierotti</LastName><ForeName>Livia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Downing</LastName><ForeName>Harriet</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Phelan</LastName><ForeName>Jody</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Infection Biology, Faculty of Infectious and Tropical Diseases, LSHTM, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Warren-Gash</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Disease Epidemiology, Faculty of Epidemiology and Population Health, LSHTM, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ngozi</LastName><ForeName>Kalu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawe</LastName><ForeName>Fiona</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Office for National Statistics, Newport, South Wales, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Relton</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Epidemiology and Population Health, LSHTM, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Christensen</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hay</LastName><ForeName>Alastair D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mangtani</LastName><ForeName>Punam</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nguipdop-Djomo</LastName><ForeName>Patrick</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene &amp; Tropical Medicine, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denholm</LastName><ForeName>Rachel</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Population Health Sciences, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Academic Primary Care, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Bristol Biomedical Research Centre, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Health Data Research UK (HDR UK) South-West, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004739" MajorTopicYN="N" Type="Geographic">England</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012574" MajorTopicYN="Y">Schools</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000302" MajorTopicYN="N">isolation &amp; purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>18</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>22</Day><Hour>13</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>22</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38776311</ArticleId><ArticleId IdType="pmc">PMC11111005</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0303892</ArticleId><ArticleId IdType="pii">PONE-D-23-26357</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zimmermann P, Pittet LF, Curtis N. How Common Is Long COVID in Children and Adolescents? The Pediatric Infectious Disease Journal. 2021. doi: 10.1097/INF.0000000000003328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000003328</ArticleId><ArticleId IdType="pmc">PMC8575095</ArticleId><ArticleId IdType="pubmed">34870392</ArticleId></ArticleIdList></Reference><Reference><Citation>He J, Guo Y, Mao R, Zhang J. Proportion of asymptomatic coronavirus disease 2019: A systematic review and meta-analysis. J Med Virol. 2021;93(2):820&#x2013;30. doi: 10.1002/jmv.26326</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26326</ArticleId><ArticleId IdType="pmc">PMC7404334</ArticleId><ArticleId IdType="pubmed">32691881</ArticleId></ArticleIdList></Reference><Reference><Citation>Sah P, Fitzpatrick MC, Zimmer CF, Abdollahi E, Juden-Kelly L, Moghadas SM, et al.. Asymptomatic SARS-CoV-2 infection: A systematic review and meta-analysis. Proc Natl Acad Sci U S A. 2021;118(34). doi: 10.1073/pnas.2109229118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2109229118</ArticleId><ArticleId IdType="pmc">PMC8403749</ArticleId><ArticleId IdType="pubmed">34376550</ArticleId></ArticleIdList></Reference><Reference><Citation>Molteni E, Sudre CH, Canas LS, Bhopal SS, Hughes RC, Antonelli M, et al.. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2. Lancet Child Adolesc Health. 2021;5(10):708&#x2013;18. doi: 10.1016/S2352-4642(21)00198-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00198-X</ArticleId><ArticleId IdType="pmc">PMC8443448</ArticleId><ArticleId IdType="pubmed">34358472</ArticleId></ArticleIdList></Reference><Reference><Citation>Penner J, Abdel-Mannan O, Grant K, Maillard S, Kucera F, Hassell J, et al.. 6-month multidisciplinary follow-up and outcomes of patients with paediatric inflammatory multisystem syndrome (PIMS-TS) at a UK tertiary paediatric hospital: a retrospective cohort study. Lancet Child Adolesc Health. 2021;5(7):473&#x2013;82. doi: 10.1016/S2352-4642(21)00138-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(21)00138-3</ArticleId><ArticleId IdType="pubmed">34043958</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott J, Whitaker M, Bodinier B, Eales O, Riley S, Ward H, et al.. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18(9):e1003777. doi: 10.1371/journal.pmed.1003777</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003777</ArticleId><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, Zhang S, Zhang R, Chen X, Wang Y, Zhu C. Epidemiological and Clinical Characteristics of COVID-19 in Children: A Systematic Review and Meta-Analysis. Front Pediatr. 2020;8:591132. doi: 10.3389/fped.2020.591132</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2020.591132</ArticleId><ArticleId IdType="pmc">PMC7667131</ArticleId><ArticleId IdType="pubmed">33224909</ArticleId></ArticleIdList></Reference><Reference><Citation>Coronavirus (COVID-19) vaccination uptake in school pupils, England: up to 22 July 2022 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/articles/coronaviruscovid19vaccinationuptakeinschoolpupilsengland/latest Accessed 24/03/2023.</Citation></Reference><Reference><Citation>Stephenson T, Pinto Pereira S, Shafran R, De Stavola B, Rojas N, McOwat K, et al.. Long COVID&#x2014;the physical and mental health of children and non-hospitalised young people 3 months after SARS-CoV-2 infection; a national matched cohort study (The CLoCk) Study
https://www.researchsquare.com/article/rs-798316/v1 Accessed 25/11/2021.</Citation></Reference><Reference><Citation>Warren-Gash C, Lacey A, Cook S, Stocker D, Toon S, Lelii F, et al.. Post-COVID-19 condition and persisting symptoms in English schoolchildren: repeated surveys to March 2022. BMC Infect Dis. 2023;23(1):201. doi: 10.1186/s12879-023-08203-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08203-1</ArticleId><ArticleId IdType="pmc">PMC10075149</ArticleId><ArticleId IdType="pubmed">37020190</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 rapid guideline: managing the long-term effects of COVID-19 https://www.nice.org.uk/guidance/ng188 Accessed 22/09/21.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 Accessed 05/05/2022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Allin B, Nugawela MD, Rojas N, Dalrymple E, Pinto Pereira S, et al.. Long COVID (post-COVID-19 condition) in children: a modified Delphi process. Arch Dis Child. 2022. doi: 10.1136/archdischild-2021-323624</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/archdischild-2021-323624</ArticleId><ArticleId IdType="pmc">PMC8983414</ArticleId><ArticleId IdType="pubmed">35365499</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Schools Infection Survey: methods and further information https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/methodologies/covid19schoolsinfectionsurveymethodsandfurtherinformation Accessed 24/03/2023.</Citation></Reference><Reference><Citation>COVID-19 Mapping and Mitigation in Schools https://commins.org.uk/ Accessed 01/03/22.</Citation></Reference><Reference><Citation>A system-wide dataset for Bristol, North Somerset, and South Gloucestershire https://bnssghealthiertogether.org.uk/population-health-management/ Accessed 25/11/2021.</Citation></Reference><Reference><Citation>International Statistical Classification of Diseases and Related Health Problems 10th Revision https://icd.who.int/browse10/2019/en Accessed 09/11/2021.</Citation></Reference><Reference><Citation>BNF for Children https://bnfc.nice.org.uk/ Accesed 27/01/2022.</Citation></Reference><Reference><Citation>Looker KJ, Bell M, Skerry R, Pike L, Lewis SJ, Relton CL, et al. https://commins.org.uk/documents/Long-COVID-in-children-report-21_07_21.pdf Long COVID in children: A report summarising the views of young people, parents and doctors. 2021.</Citation></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, et al.. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453&#x2013;7. doi: 10.1016/S0140-6736(07)61602-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61602-X</ArticleId><ArticleId IdType="pubmed">18064739</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguipdop-Djomo P, Oswald WE, Halliday KE, Cook S, Sturgess J, Sundaram N, et al.. Risk factors for SARS-CoV-2 infection in primary and secondary school students and staff in England in the 2020/2021 school year: a longitudinal study. Int J Infect Dis. 2023;128:230&#x2013;43. doi: 10.1016/j.ijid.2022.12.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.030</ArticleId><ArticleId IdType="pmc">PMC9815858</ArticleId><ArticleId IdType="pubmed">36621754</ArticleId></ArticleIdList></Reference><Reference><Citation>Halliday KE, Nguipdop-Djomo P, Oswald WE, Sturgess J, Allen E, Sundaram N, et al.. The COVID-19 Schools Infection Survey in England: Protocol and Participation Profile for a Prospective Observational Cohort Study. JMIR Res Protoc. 2022;11(11):e34075. doi: 10.2196/34075</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/34075</ArticleId><ArticleId IdType="pmc">PMC9651002</ArticleId><ArticleId IdType="pubmed">35635843</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>